Results 61 to 70 of about 3,155 (190)

Diffusion curves of FAM-SP after binding with different amounts of NK1R-NLPs.

open access: yes, 2012
Sample a to e represent 80 µL FAM-SP binding with 0.5, 4, 8, 12, 20 µL NK1R-NLP complexes respectively. Sample f to h represent 20, 10, 4, 2 µL FAM-SP binding with 10 µL NK1R-NLPs complexes respectively.
John Voss (131458)   +6 more
core   +1 more source

Characterisation of sleep apneas and respiratory circuitry in mice lacking CDKL5

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary CDKL5 deficiency disorder is a rare genetic disease caused by mutations in the CDKL5 gene. Central apneas during wakefulness have been reported in patients with CDKL5 deficiency disorder. Studies on CDKL5‐knockout mice, a CDKL5 deficiency disorder model, reported sleep apneas, but it is still unclear whether these events are central (central ...
Gabriele Matteoli   +12 more
wiley   +1 more source

Functional identification of NR2 subunits contributing to NMDA receptors on substance P receptor-expressing dorsal horn neurons

open access: yesMolecular Pain, 2008
NMDA receptors are important elements in pain signaling in the spinal cord dorsal horn. They are heterotetramers typically composed of two NR1 and two of four NR2 subunits: NR2A-2D.
MacDermott Amy B   +2 more
doaj   +1 more source

NK1r and sst2A in superficial dorsal horn.

open access: yes, 2013
Confocal image showing a single optical section through part of laminae I and IIo, scanned to reveal NK1r (green) and sst2A (magenta). a: Two NK1r-immunoreactive cell bodies (arrows) are visible in lamina I, surrounded by a plexus of labelled dendrites ...
Andrew J. Todd (179384)   +3 more
core   +1 more source

The effect of substance P and its common in vivo‐formed metabolites on MRGPRX2 and human mast cell activation

open access: yesPharmacology Research & Perspectives, 2022
The tachykinin neuropeptide substance P (SP) is the canonical agonist peptide for the neurokinin 1 receptor (NK1R). More recently, it has also been shown to activate the Mas‐related G protein‐coupled receptor X2 (MRGPRX2) receptor on mast cells (MCs ...
Lin Hsin   +7 more
doaj   +1 more source

Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis

open access: yesCells, 2023
Primary Sjögren’s Syndrome (pSS) is a systemic autoimmune disease that primarily attacks the lacrimal and salivary glands, resulting in impaired secretory function characterized by xerostomia and xerophthalmia.
Pamela Rosso   +11 more
doaj   +1 more source

Pathogenic role of the SP/ NK1R system in GBM cells through inhibiting the thioredoxin system.

open access: yesIranian journal of basic medical sciences, 2021
Glioblastoma multiforme (GBM), a highly aggressive Grade IV brain tumor, is a significant public health issue due to its poor prognosis and incurability. Neuropeptide substance P (SP) plays a critical role in GBM tumor growth and development via activation of neurokinin-1receptor (NK1R).
Ghahremani, Fatemeh   +5 more
openaire   +3 more sources

On‐DNA Nitro Reduction for Use in DNA‐Encoded Library Synthesis: Methods, Applications, and Challenges

open access: yesAsian Journal of Organic Chemistry, Volume 15, Issue 10, October 2026.
Reducing aryl nitro groups provides DNA‐linked anilines for use in benzimidazole synthesis and other scaffold‐forming reactions during the construction of DNA‐encoded libraries. This review examines transfer hydrogenation and Fe(II)‐, dithionite/viologen‐, diboron‐, and Pd‐based methods, focusing on how reaction efficiency, chemoselectivity, DNA ...
Yeongjoo Suh   +3 more
wiley   +1 more source

Additional file 1 of Aprepitant attenuates NLRC4-dependent neuronal pyroptosis via NK1R/PKCδ pathway in a mouse model of intracerebral hemorrhage

open access: yes, 2022
Additional file 1.
John H. Zhang (7537538)   +7 more
core   +1 more source

The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors

open access: yesCurrent Oncology, 2021
Rhabdoid tumors (RT) are among the most aggressive tumors in early childhood. Overall survival remains poor, and treatment only effectively occurs at the cost of high toxicity and late adverse effects. It has been reported that the neurokinin-1 receptor/
Julian Kolorz   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy